BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Institute for Biohealth Innovation - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ibi.gmu.edu
X-WR-CALDESC:Events for The Institute for Biohealth Innovation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230414T120000
DTEND;TZID=America/New_York:20230414T120000
DTSTAMP:20260530T051406
CREATED:20230411T010844Z
LAST-MODIFIED:20230411T192858Z
UID:10000052-1681473600-1681473600@ibi.gmu.edu
SUMMARY:Lunch and Learn: A Novel mRNA Vaccine Platform for HIV-1
DESCRIPTION:Sponsors: Virginia Bio-Connect\, GO Virginia\nHosted by: George Mason University’s Center for Infectious Disease Research and Northern Virginia BioHub \nSpeaker: Dr. Paolo Lusso\, MD\, PhD \nDr. Lusso received his M.D.\, summa cum laude\, from the University of Turin and his Ph.D. from the Ministry of Scientific and Technologic Research\, Rome\, Italy. He is a board-certified specialist in internal medicine and in infectious diseases. He came to NIH for the first time in 1986 to work in the Laboratory of Tumor Cell Biology under Dr. Robert C. Gallo at the National Cancer Institute. He returned to Italy in 1994\, where he created the Laboratory of Human Virology at the San Raffaele Scientific Institute in Milan and became associate professor of infectious diseases at the University of Cagliari. In 2006\, he again joined NIH\, where he became chief of the Viral Pathogenesis Section in the Laboratory of Immunoregulation. He is an executive editor of Current HIV Research and a member of the editorial board of several other journals. He is an elected member or the European Molecular Biology Organization (EMBO) and a Fellow of the American Academy of Microbiology (AAM). \nDr. Lusso’s major areas of research include: \n\nNovel approaches (including mRNA) to the development of an HIV-1 vaccine\nStructure-function relationships in the HIV-1 envelope\nStructure-based design of improved therapeutic monoclonal antibodies\n Molecular basis of HIV-1 immune evasion\n Role of chemokines and other endogenous immune modulators in HIV-1 disease\n\nPlease join us in welcoming Dr Lusso to the Mason SciTech campus. \nLunch will be provided at the seminar.
URL:https://ibi.gmu.edu/event/lunch-and-learn-a-novel-mrna-vaccine-platform-for-hiv-1/
LOCATION:Katherine G. Johnson Hall\, Room 132\, 10890 George Mason Circle\, Manassas\, VA\, 20109\, United States
END:VEVENT
END:VCALENDAR